Anhui Anke Biotechnology (Group) Co., Ltd. (SHE:300009)
China · Delayed Price · Currency is CNY 9.81
-0.15 (-1.51%)
At close: Feb 13, 2026
SHE:300009 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 668.71 | 706.95 | 847.23 | 703.26 | 206.63 | 358.96 |
Depreciation & Amortization | 120.96 | 120.96 | 101.11 | 86.57 | 80.95 | 65.99 |
Other Amortization | 3.19 | 3.19 | 1.94 | 2.3 | 7.79 | 4.31 |
Loss (Gain) From Sale of Assets | -1.09 | -1.09 | -0.12 | 1.2 | -1.68 | 0.02 |
Asset Writedown & Restructuring Costs | 0.15 | 0.15 | 1.49 | 4.47 | 323.44 | 0.03 |
Loss (Gain) From Sale of Investments | -26.04 | -26.04 | 15.44 | -24.66 | -3.86 | 15.42 |
Provision & Write-off of Bad Debts | 7.19 | 7.19 | 20.12 | 5.37 | 4.62 | 3.84 |
Other Operating Activities | 189.03 | 15.86 | 13.3 | 11.02 | 3.7 | -7.73 |
Change in Accounts Receivable | -20.45 | -20.45 | -214.07 | -37.65 | -114.19 | -18.56 |
Change in Inventory | -69.93 | -69.93 | -30.55 | -36.62 | -27.47 | -31.25 |
Change in Accounts Payable | -69.59 | -69.59 | 131.79 | -75.73 | 123.87 | 82.45 |
Change in Other Net Operating Assets | 35.37 | 35.37 | 81.68 | 16.37 | 1.2 | - |
Operating Cash Flow | 820.31 | 685.37 | 952.97 | 698.98 | 592.17 | 464.8 |
Operating Cash Flow Growth | 9.66% | -28.08% | 36.34% | 18.04% | 27.41% | 57.22% |
Capital Expenditures | -71.79 | -117.22 | -195.34 | -474.34 | -131.23 | -138.52 |
Sale of Property, Plant & Equipment | 0.34 | 0.89 | 0.25 | 3.58 | 1.76 | 0.43 |
Cash Acquisitions | 22.46 | -1.2 | -8.13 | - | - | - |
Divestitures | -12.02 | - | 1.89 | 2.01 | - | - |
Investment in Securities | -459.69 | -91.42 | -447.98 | -101.07 | -103.07 | -251.23 |
Other Investing Activities | 23.2 | 38.7 | 32.04 | 25.94 | 61.44 | 25.97 |
Investing Cash Flow | -497.52 | -170.25 | -617.27 | -543.88 | -171.1 | -363.35 |
Short-Term Debt Issued | - | 5 | - | 3 | - | - |
Total Debt Issued | 7 | 5 | - | 3 | - | - |
Short-Term Debt Repaid | - | - | -3.03 | - | -14 | - |
Long-Term Debt Repaid | - | -10.37 | -7.24 | -7.56 | -3.63 | -14 |
Total Debt Repaid | -15.37 | -10.37 | -10.27 | -7.56 | -17.63 | -14 |
Net Debt Issued (Repaid) | -8.37 | -5.37 | -10.27 | -4.56 | -17.63 | -14 |
Issuance of Common Stock | - | - | 18.81 | 167.35 | - | - |
Repurchase of Common Stock | - | - | - | -40.06 | - | - |
Common Dividends Paid | -418.01 | -415.57 | -411.05 | -327.61 | -273.52 | -159.19 |
Other Financing Activities | -57.02 | -54.44 | 1.51 | 51.73 | 14.85 | 46.83 |
Financing Cash Flow | -483.4 | -475.38 | -400.99 | -153.15 | -276.3 | -126.35 |
Foreign Exchange Rate Adjustments | -3.04 | 0.08 | -0.11 | 0.06 | -0.01 | -0.07 |
Net Cash Flow | -163.65 | 39.82 | -65.4 | 2.01 | 144.76 | -24.97 |
Free Cash Flow | 748.51 | 568.15 | 757.64 | 224.64 | 460.94 | 326.27 |
Free Cash Flow Growth | 25.64% | -25.01% | 237.27% | -51.27% | 41.27% | 198.92% |
Free Cash Flow Margin | 29.04% | 22.40% | 26.44% | 9.64% | 21.25% | 19.18% |
Free Cash Flow Per Share | 0.45 | 0.34 | 0.45 | 0.14 | 0.29 | 0.20 |
Cash Income Tax Paid | 227.41 | 223.79 | 226.59 | 233.17 | 193.24 | 166.53 |
Levered Free Cash Flow | 432.1 | 365.07 | 591.82 | 194.46 | 450.42 | 259.16 |
Unlevered Free Cash Flow | 433.35 | 366.58 | 592.99 | 195.41 | 451.44 | 260.17 |
Change in Working Capital | -141.79 | -141.79 | -47.53 | -90.56 | -29.42 | 23.96 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.